Holen Sie sich die Stockscreener-App
2.84
2.07%
-0.06
Handel nachbörslich:
2.84
Schlusskurs vom Vortag:
$2.90
Offen:
$2.92
24-Stunden-Volumen:
6,466
Relative Volume:
0.45
Marktkapitalisierung:
$3.91M
Einnahmen:
$5.67M
Nettoeinkommen (Verlust:
$-13.98M
KGV:
-0.1321
EPS:
-21.5
Netto-Cashflow:
$-15.30M
1W Leistung:
-33.02%
1M Leistung:
-28.28%
6M Leistung:
-6.89%
1J Leistung:
-5.65%
1-Tages-Spanne:
$2.81
$2.92
1-Wochen-Bereich:
$2.80
$4.40
52-Wochen-Spanne:
$1.8512
$5.34
Arcadia Biosciences Inc Stock (RKDA) Company Profile
Firmenname
Arcadia Biosciences Inc
Sektor
Branche
Telefon
530-756-7077
Adresse
202 COUSTEAU PLACE, DAVIS, CA
Vergleichen Sie RKDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| RKDA | 2.84 | 3.91M | 5.67M | -13.98M | -15.30M | -21.50 |
| KHC | 31.07 | 38.01B | 26.13B | 1.37B | 3.00B | 2.42 |
| GIS | 62.88 | 34.91B | 19.80B | 2.40B | 2.78B | 4.10 |
| K | 80.60 | 27.75B | 12.80B | 1.01B | 927.00M | 2.50 |
| MKC | 74.62 | 19.89B | 6.68B | 792.60M | 774.40M | 2.40 |
| HRL | 29.40 | 16.12B | 11.98B | 780.78M | 902.87M | 1.61 |
Arcadia Biosciences Inc Stock (RKDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-08-17 | Bestätigt | H.C. Wainwright | Buy |
| 2017-05-12 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2015-06-09 | Eingeleitet | Credit Suisse | Outperform |
| 2015-06-09 | Eingeleitet | Piper Jaffray | Overweight |
Arcadia Biosciences Inc Aktie (RKDA) Neueste Nachrichten
Arcadia Biosciences' Q3 Earnings Miss Estimates, Sales Increase Y/Y - Yahoo Finance
Arcadia Biosciences (FRA:17D) 3-Year FCF Growth Rate : 54.40% (As of Jun. 2024) - GuruFocus.com
Arcadia Biosciences (FRA:17D) Profitability Rank : 1 (As of Jun. 2024) - GuruFocus.com
Arcadia Biosciences Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q3 2024 Earnings Call Transcript - Insider Monkey
Arcadia Biosciences: Q3 Earnings Snapshot - Darien Times
Arcadia Biosciences Inc (RKDA) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic Challenges - GuruFocus.com
Arcadia Biosciences Inc (RKDA) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
Arcadia Biosciences Reports Strong Q3 2024 Growth - TipRanks
Arcadia Biosciences (RKDA) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2024 Financial Results and Business Highlights - Quantisnow
Arcadia Biosciences Inc (RKDA) Q3 2024 Earnings Report Preview: What To Look For - GuruFocus.com
CFO takes over as CEO at Arcadia - Food Business News
Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2024 Financial Results and Business Highlights Conference Call - Quantisnow
Zacks Industry Outlook Highlights Bunge, West Fraser Timber, Hydrofarm and Arcadia Biosciences - Yahoo Finance
Arcadia Biosciences stock hits 52-week high at $4 - Investing.com India
Arcadia Biosciences stock hits 52-week high at $4 By Investing.com - Investing.com South Africa
Resistant Starch Market: 2024 Global Future Scope, - openPR
ARDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Simplify Asset Management Inc. Buys 248,000 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat
ARCA biopharma (NASDAQ:ABIO) Earns Sell Rating from Analysts at StockNews.com - Defense World
Ares Capital Co. (NASDAQ:ARCC) Receives $21.71 Consensus PT from Brokerages - Defense World
Seven Eight Capital LP Trims Stock Holdings in Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
WINTON GROUP Ltd Sells 14,344 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) - Defense World
Arcellx Sees Unusually Large Options Volume (NASDAQ:ACLX) - Defense World
Ardelyx (NASDAQ:ARDX) Trading Down 3.6% - Defense World
Arcturus Therapeutics (NASDAQ:ARCT) Shares Down 3.5% - Defense World
Arko gains for a second day after report it's mulling sale of convenience stores - Seeking Alpha
Metric Deep Dive: Understanding Ares Capital Corp (ARCC) Through its Ratios - The Dwinnex
Aclaris Therapeutics (NASDAQ:ACRS) Receives “Neutral” Rating from HC Wainwright - Defense World
Arcus Biosciences, Inc. (NYSE:RCUS) Receives Average Recommendation of “Buy” from Brokerages - Defense World
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acadia Healthcare Company, Inc.ACHC - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming DeadlinesARDX - PR Newswire
Aclaris Therapeutics (NASDAQ:ACRS) Receives "Neutral" Rating from HC Wainwright - MarketBeat
First Week of January 2027 Options Trading For Ares Capital (ARCC) - Nasdaq
Ares Capital Co. (NASDAQ:ARCC) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Ares Capital (ARCC) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Arcturus Therapeutics Holdings Inc (ARCT) expanding its growth trajectory ahead - SETE News
R1.3bn start to ARC’s financial year - Moneyweb
ARC Investments firms over 4% on strong portfolio growth - Moneyweb
Here's Why Investors Should Invest in Arcturus Stock Now - Zacks Investment Research
Recent Insider Activity Suggests Potential Gains for Arcutis Biotherapeutics Inc (ARQT) - Knox Daily
ARDX Investors Have Opportunity to Lead Ardelyx, Inc.Securities Fraud Lawsuit with the Schall Law Firm - Stockhouse Publishing
Arcturus Therapeutics Holdings Inc [ARCT] Insider Activity: An Update for Investors - Knox Daily
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Consensus Rating of “Buy” by Brokerages - Defense World
ACHC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Acadia Healthcare Company, Inc. and Encourages Investors to Contact the Firm! - PR Newswire
Arcadia Biosciences ~ SONOVA 400 - Natural Products Insider
Amendment: Arcadia Biosciences Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits - Quantisnow
Wheat no longer in Arcadia’s future - Food Business News
Analysts Offer Predictions for Arcadia Biosciences, Inc.’s Q3 2024 Earnings (NASDAQ:RKDA) - Defense World
Arcadia shifting focus away from wheat - World Grain
Finanzdaten der Arcadia Biosciences Inc-Aktie (RKDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.79%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):